Literature DB >> 33566259

LncRNA XIST Promotes Atherosclerosis by Regulating miR-599/TLR4 Axis.

Kechun Yang1, Yun Xue1, Xiaoya Gao2.   

Abstract

Long noncoding RNAs (lncRNAs) have been reported to be implicated in various biological and pathological processes. However, the function and mechanism of XIST in vascular smooth muscle cells (VSMCs) remains unknown. The levels of XIST, miR-599, and TLR4 were tested by RT-qPCR. VSMCs and human mononuclear cells (U937) treated with ox-LDL were used as atherosclerosis (AS) cell models. The CCK-8 assay was adopted to detect cell viability. Cell apoptosis was examined by the TUNEL assay. A dual-luciferase reporter assay was employed to investigate the interaction between miR-599 and XIST or TLR4. In this research, we uncovered that the XIST level was elevated in the serum of AS patients and ox-LDL-treated AS cell models. Functional analysis revealed that XIST depletion restrained cell proliferation, while induced the apoptosis in AS cell models. Besides, miR-599 was verified to be a direct downstream target of XIST and miR-599 inhibitor reversed the effects of XIST knockdown on AS progression. Finally, we demonstrated that XIST increased TLR4 expression by serving as a ceRNA of miR-599. All these findings manifested the role of the XIST/miR-599/TLR4 axis in AS development.

Entities:  

Keywords:  Atherosclerosis (AS); TLR4; XIST; miR-599

Mesh:

Substances:

Year:  2021        PMID: 33566259     DOI: 10.1007/s10753-020-01391-x

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  7 in total

1.  miR-365b-3p inhibits the cell proliferation and migration of human coronary artery smooth muscle cells by directly targeting ADAMTS1 in coronary atherosclerosis.

Authors:  Yunfei Qu; Ning Zhang
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

2.  The suppression of ox-LDL-induced inflammatory response and apoptosis of HUVEC by lncRNA XIAT knockdown via regulating miR-30c-5p/PTEN axis.

Authors:  W-N Hu; Z-Y Duan; Q Wang; D-H Zhou
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-09       Impact factor: 3.507

3.  Role of Paraoxonase 1 Activity and Oxidative/Antioxidative Stress Markers in Patients with Acute Cerebral Infarction.

Authors:  Hui Zhu; Teng Zhao; Jingyao Liu
Journal:  Clin Lab       Date:  2018-06-01       Impact factor: 1.138

4.  LncRNA TUG1 promotes proliferation of vascular smooth muscle cell and atherosclerosis through regulating miRNA-21/PTEN axis.

Authors:  F-P Li; D-Q Lin; L-Y Gao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-11       Impact factor: 3.507

5.  MicroRNA-599 suppresses glioma progression by targeting RAB27B.

Authors:  Yu Jiang; Xiaohui Wang; Ji Zhang; Renchun Lai
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

6.  lncRNA 430945 promotes the proliferation and migration of vascular smooth muscle cells via the ROR2/RhoA signaling pathway in atherosclerosis.

Authors:  Chuan Cui; Xing Wang; Xiao-Ming Shang; Li Li; Yi Ma; Guo-Yu Zhao; Yu-Xin Song; Xue-Bin Geng; Bi-Qiong Zhao; Mei-Rong Tian; Hong-Ling Wang
Journal:  Mol Med Rep       Date:  2019-04-05       Impact factor: 2.952

7.  Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer.

Authors:  Keqin Zhou; Jinrui Yang; Xurui Li; Wenjie Chen
Journal:  Exp Ther Med       Date:  2019-08-29       Impact factor: 2.447

  7 in total
  2 in total

1.  A construction and comprehensive analysis of the immune-related core ceRNA network and infiltrating immune cells in peripheral arterial occlusive disease.

Authors:  Zhiyong Chen; Jiahui Xu; Binshan Zha; Jun Li; Yongxiang Li; Huan Ouyang
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

2.  Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) promotes the inflammation and apoptosis of otitis media with effusion through targeting microRNA (miR)-495 and activation of p38 MAPK signaling pathway.

Authors:  Yajuan Hu; Hongjun Dong; Jingjing Huang; Jie Huang; Dandan Tao; Chao Huang; Lei Hu; Hao Xu; Yan Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.